Advertisement
Research ArticleArticle

Lapatinib and Obatoclax Kill Tumor Cells through Blockade of ERBB1/3/4 and through Inhibition of BCL-xL and MCL-1

Nichola Cruickshanks, Hossein A. Hamed, M. Danielle Bareford, Andrew Poklepovic, Paul B. Fisher, Steven Grant and Paul Dent
Molecular Pharmacology May 2012, 81 (5) 748-758; DOI: https://doi.org/10.1124/mol.112.077586

Article Information

vol. 81 no. 5 748-758
DOI 
https://doi.org/10.1124/mol.112.077586
PubMed 
22357666
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received January 3, 2012
  • Accepted February 22, 2012
  • Published online April 16, 2012.

Article Versions

Copyright & Usage 
Copyright © 2012 The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Nichola Cruickshanks,
  2. Hossein A. Hamed,
  3. M. Danielle Bareford,
  4. Andrew Poklepovic,
  5. Paul B. Fisher,
  6. Steven Grant and
  7. Paul Dent
  1. Departments of Neurosurgery (N.C., H.A.H., M.D.B., P.D.), Human and Molecular Genetics (P.B.F.), and Medicine (A.P., S.G.), Virginia Commonwealth University, Richmond, Virginia
  1. Address correspondence to:
    Dr. Paul Dent, 401 College Street, Massey Cancer Center, Box 980035, Department of Neurosurgery, Virginia Commonwealth University, Richmond, VA 23298-0035. E-mail: pdent{at}vcu.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: February 2012 to September 2023

AbstractFullPdf
Feb 2012142098
Mar 20121340128
Apr 20122642585
May 20122222765
Jun 2012921536
Jul 2012533551
Aug 2012631334
Sep 2012391635
Oct 201238723
Nov 2012271123
Dec 2012391020
Jan 2013791328
Feb 20132195
Mar 201333810
Apr 201353612
May 2013511318
Jun 20139920
Jul 2013491022
Aug 201310815
Sep 2013321214
Oct 2013372114
Nov 2013241614
Dec 2013292520
Jan 2014211512
Feb 2014171218
Mar 2014201015
Apr 201491014
May 201491616
Jun 201419517
Jul 20141654
Aug 20141094
Sep 20147716
Oct 201410517
Nov 201429650
Dec 201420715
Jan 201520208
Feb 20151377
Mar 20158397
Apr 2015141012
May 201523118
Jun 201527138
Jul 2015361119
Aug 201530129
Sep 2015212111
Oct 201515711
Nov 2015888
Dec 20156123
Jan 201622527
Feb 201618519
Mar 201616724
Apr 2016546
May 2016122314
Jun 201612812
Jul 2016261517
Aug 201619613
Sep 2016241017
Oct 20167155
Nov 20166117
Dec 20162144
Jan 20172299
Feb 20170172
Mar 20170192
Apr 20170151
May 20173153
Jun 20170124
Jul 20170185
Aug 20171203
Sep 20173107
Oct 2017092
Nov 20170124
Dec 20170105
Jan 20181164
Feb 2018095
Mar 20181125
Apr 20180125
May 20181103
Jun 20180142
Jul 20181172
Aug 20180131
Sep 20180191
Oct 20180165
Nov 20180126
Dec 20181923
Jan 20192007
Feb 20192022
Mar 20192514
Apr 20192613
May 201911110
Jun 2019909
Jul 20191303
Aug 2019925
Sep 20191513
Oct 20192034
Nov 20191426
Dec 20191012
Jan 2020921
Feb 20201321
Mar 20201213
Apr 2020401
May 2020611
Jun 20202101
Jul 20201200
Aug 2020604
Sep 2020712
Oct 2020924
Nov 20201500
Dec 20202603
Jan 20212026
Feb 2021825
Mar 20211821
Apr 20211114
May 20212541
Jun 2021722
Jul 20211113
Aug 2021324
Sep 20211928
Oct 20211012
Nov 20211618
Dec 2021812
Jan 20221612
Feb 20221712
Mar 20222233
Apr 20222053
May 20221211
Jun 20221512
Jul 20221913
Aug 20221313
Sep 202210916
Oct 202215722
Nov 20223613
Dec 20221011
Jan 20232310
Feb 20232221
Mar 2023810
Apr 20231122
May 2023901
Jun 2023710
Jul 20232414
Aug 2023322
Sep 2023820

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleArticle

Lapatinib, Obatoclax, and CNS Tumors

Nichola Cruickshanks, Hossein A. Hamed, M. Danielle Bareford, Andrew Poklepovic, Paul B. Fisher, Steven Grant and Paul Dent
Molecular Pharmacology May 1, 2012, 81 (5) 748-758; DOI: https://doi.org/10.1124/mol.112.077586
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement